Calder Biosciences, Inc. Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Calder Biosciences, Inc. is a nano-scale molecular engineering company that is applying its platform technology to develop novel respiratory syncytial virus (RSV) and universal Influenza vaccines that both represent multi-billion dollar market opportunities with mitigated clinical risk.